HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
Alibaba
BABA
|
+$274M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$108M |
| 3 |
AbbVie
ABBV
|
+$96.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$91.7M |
| 5 |
FirstEnergy
FE
|
+$73.7M |
Top Sells
| 1 |
FDC
First Data Corporation
FDC
|
+$237M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$212M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$153M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$151M |
| 5 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$142M |
Sector Composition
| 1 | Consumer Discretionary | 20.52% |
| 2 | Technology | 14.2% |
| 3 | Financials | 11.57% |
| 4 | Healthcare | 9.6% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF.B
1651
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $618K | ﹤0.01% |
70,672
-76,982
| -52% | -$673K |
|
1652
BBVA Argentina
BBAR
$1.84B
| $617K | ﹤0.01% |
142,382
-310,816
| -69% | -$1.35M |
|
1653
Monro
MNRO
$519M
| $616K | ﹤0.01% |
7,807
+1,659
| +27% | +$131K |
|
1654
Akero Therapeutics
AKRO
$3.48B
| $615K | ﹤0.01% |
+27,014
| New | +$615K |
|
|
CHS
1655
DELISTED
Chicos FAS, Inc.
CHS
| $615K | ﹤0.01% |
152,625
+4,568
| +3% | +$18.4K |
|
1656
Ecovyst
ECVT
$1.06B
| $612K | ﹤0.01% |
38,364
+25,499
| +198% | +$407K |
|
1657
ENI
E
$52.3B
| $611K | ﹤0.01% |
20,040
-342
| -2% | -$10.4K |
|
1658
iShares MSCI USA Momentum Factor ETF
MTUM
$18.8B
| $611K | ﹤0.01% |
+5,122
| New | +$611K |
|
1659
Seaboard Corp
SEB
$3.78B
| $608K | ﹤0.01% |
139
+11
| +9% | +$48.1K |
|
1660
Global Net Lease
GNL
$1.81B
| $607K | ﹤0.01% |
31,146
+18,867
| +154% | +$368K |
|
|
DHC
1661
Diversified Healthcare Trust
DHC
$1.07B
| $605K | ﹤0.01% |
65,393
+3,636
| +6% | +$33.6K |
|
|
ONDK
1662
DELISTED
On Deck Capital, Inc.
ONDK
| $603K | ﹤0.01% |
+179,362
| New | +$603K |
|
|
HMSY
1663
DELISTED
HMS Holdings Corp.
HMSY
| $601K | ﹤0.01% |
17,411
-284
| -2% | -$9.8K |
|
1664
GameStop
GME
$11.2B
| $600K | ﹤0.01% |
435,040
+13,040
| +3% | +$18K |
|
|
MCBC
1665
DELISTED
Macatawa Bank Corp
MCBC
| $598K | ﹤0.01% |
+57,580
| New | +$598K |
|
|
DOOR
1666
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $598K | ﹤0.01% |
10,298
-19,258
| -65% | -$1.12M |
|
1667
OceanFirst Financial
OCFC
$1.04B
| $596K | ﹤0.01% |
+25,270
| New | +$596K |
|
|
XHR
1668
Xenia Hotels & Resorts
XHR
$1.41B
| $596K | ﹤0.01% |
28,185
+11,991
| +74% | +$254K |
|
|
NVTA
1669
DELISTED
Invitae Corporation
NVTA
| $593K | ﹤0.01% |
30,750
-6,245
| -17% | -$120K |
|
1670
Ziff Davis
ZD
$1.5B
| $591K | ﹤0.01% |
7,492
-1,119
| -13% | -$88.3K |
|
|
EGRX
1671
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $590K | ﹤0.01% |
+10,421
| New | +$590K |
|
|
RARX
1672
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $589K | ﹤0.01% |
+24,896
| New | +$589K |
|
1673
Hilltop Holdings
HTH
$2.18B
| $588K | ﹤0.01% |
24,591
+3,324
| +16% | +$79.5K |
|
1674
Antero Resources
AR
$10.2B
| $587K | ﹤0.01% |
194,548
+131,248
| +207% | +$396K |
|
1675
Jazz Pharmaceuticals
JAZZ
$7.65B
| $586K | ﹤0.01% |
4,570
-1,430
| -24% | -$183K |
|